Endogenous morphinergic signaling and tumor growth
Patrick Cadet, Mads Rasmussen, Wei Zhu, Else Tonnesen, Kirk J. Mantione and George B. Stefano
[Frontiers in Bioscience 9, 3176-3186, September 1, 2004]

Delta opioid peptide (D-ALA 2, D-LEU 5) enkephalin: linking hibernation and neuroprotection
Cesar V. Borlongan, Yun Wang and Tsung-Ping Su
[Frontiers in Bioscience 9, 3392-3398, September 1, 2004]

Opioid peptides in cerebrospinal fluid-methods for analysis and their significance in the clinical perspective
Fred Nyberg
[Frontiers in Bioscience 9, 3510-3525, September 1, 2004]

Pathobiology of dynorphins in trauma and disease
Kurt F. Hauser, Jane V. Aldrich, Kevin J. Anderson, Georgy Bakalkin, MacDonald J. Christie, Edward D. Hall 1, Pamela E. Knapp, Stephen W Scheff, Indrapal N. Singh, Bryce Vissel, Amina S. Woods, Tatiana Yakovleva, and Toni S. Shippenberg
[Frontiers in Bioscience 10, 216--235, January 1, 2005]

Opioid-somatostatin interactions in regulating cancer cell growth
Anastassia Hatzoglou, Marilena Kampa and Elias Castanas
[Frontiers in Bioscience 10, 244--256, January 1, 2005]

Managing chronic pain with encapsulated cell implants releasing catecholamines and endogenous opiods
Shelley R. Winn and Dwaine F. Emerich
[Frontiers in Bioscience 10, 367--378, January 1, 2005]

The preclinical development of Medisorb® Naltrexone, a once a month long-acting injection, for the treatment of alcohol dependence
Reginald L. Dean
[Frontiers in Bioscience 10, 643-655, January 1, 2005]